I guess for me, being long on the stock, what I am liking is the continuous good news and new findings from independent researchers related to the impact of rvx-208 as evidenced by today's news release. This seems to be a completely remarkable and leading edge drug and what is more important is the leading edge thinking behind it.

It is becoming clear that epigenetics is the hot area in biotech and RVX is out in front. This area does not just impact human diseases but also many biological species.

I'm thrilled by the fast pace of news releases on new discoveries related to rvx-208 and I'm very excited by the enormous potential of Zentih Epigenetics.

GLTA

Cheers

Toinv :)